Genetic regulation of cell function in response to iron overload or chelation

Biochimica et Biophysica Acta - General Subjects

Volumn 1619, Issue 2, 2003, Pages 113-124

  Templeton, Douglas M ^a   Liu, Ying ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cell function; Chelation; Iron overload

Indexed keywords

HEME; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON; METALLOPORPHYRIN; OXYGEN; REACTIVE OXYGEN METABOLITE;

BIOSENSOR; CELL CYCLE; CELL FUNCTION; CELL HYPOXIA; ENERGY METABOLISM; FIBROSIS; IRON CHELATION; IRON METABOLISM; IRON OVERLOAD; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

MAMMALIA;

EID: 0037454654     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(02)00497-X     Document Type: Review

References (130)

1. Schneider W. Iron hydrolysis and the biochemistry of iron - the interplay of hydroxide and biogenic ligands. Chimia. 42:1988;9-20.
2. Harris W.R. Templeton D.M. Molecular and Cellular Iron Transport. 2002;1-40 Marcel Dekker, New York.
3. Templeton D.M. Molecular and Cellular Iron Transport. 2002;Marcel Dekker, New York.
4. Alcantara O., Kalidas M., Baltathakis I., Boldt D.H. Expression of multiple genes regulating cell cycle and apoptosis in differentiating hematopoietic cells is dependent on iron. Exp. Hematol. 29:2001;1060-1069.
5. Barisani D., Meneveri R., Ginelli E., Cassani C., Conte D. Iron overload and gene expression in HepG2 cells: analysis by differential display. FEBS Lett. 469:2000;208-212.
6. Ye Z., Connor J.R. Identification of iron responsive genes by screening cDNA libraries from suppression subtractive hybridization with antisense probes from three iron conditions. Nucleic Acids Res. 28:2000;1802-1807.
7. Crosa J.H. Signal transduction and transcriptional and posttranscriptional control of iron-regulated genes in bacteria. Microbiol. Mol. Biol. Rev. 61:1997;319-336.
8. Boyer A.E., Tai P.C. Characterization of the cvaA and cvi promoters of the colicin V export system: iron-dependent transcription of cvaA is modulated by downstream sequences. J. Bacteriol. 180:1998;1662-1672.
9. Angerer A., Braun V. Iron regulates transcription of the Escherichia coli ferric citrate transport genes directly and through the transcription initiation proteins. Arch. Microbiol. 169:1998;483-490.
10. Wösten M.M., Kox L.F., Chamnongpol S., Soncini F.C., Groisman E.A. A signal transduction system that responds to extracellular iron. Cell. 103:2000;113-125.
11. Ardon O., Kaplan J., Martin B.D. Templeton D.M. Molecular and Cellular Iron Transport. 2002;375-393 Marcel Dekker, New York.
12. Braun V., Hantke K. Templeton D.M. Molecular and Cellular Iron Transport. 2002;395-426 Marcel Dekker, New York.
13. Anderson G.J., Vulpe C.D. Templeton D.M. Molecular and Cellular Iron Transport. 2002;559-596 Marcel Dekker, New York.
14. Vulpe C.D., Kuo Y.M., Murphy T.L., Cowley L., Askwith C., Libina N., Gitschier J., Anderson G.J. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 21:1999;195-199.
15. Fleming R.E., Britton R.S., Waheed A., Sly W.S., Bacon B.R. Templeton D.M. Molecular and Cellular Iron Transport. 2002;189-205 Marcel Dekker, New York.
16. Kawabata H., Yang S., Hirama T., Vuong P.T., Kawano S., Gombart A.F., Koeffler H.P. Molecular cloning of transferrin receptor 2 - a new member of the transferrin receptor-like family. J. Biol. Chem. 274:1999;20826-20832.
17. Fleming R.E., Migas M.C., Holden C.C., Waheed A., Britton R.S., Tomatsu S., Bacon B.R., Sly W.S. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc. Natl. Acad. Sci. U. S. A. 97:2000;2214-2219.
18. Ponka P., Beaumont C., Richardson D.R. Function and regulation of transferrin and ferritin. Semin. Hematol. 35:1998;35-54.
19. Arosio P., Levi S. Templeton D.M. Molecular and Cellular Iron Transport. 2002;125-154 Marcel Dekker, New York.
20. Hentze M.W., Kühn L.C. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8175-8182.
21. Eisenstein R.S. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu. Rev. Nutr. 20:2000;627-662.
22. Theil E.C., Eisenstein R.S. Combinatorial mRNA regulation: iron regulatory proteins and iso-iron responsive elements (iso-IREs). J. Biol. Chem. 275:2000;40659-40662.
23. Hanson E.S., Leibold E. Templeton D.M. Molecular and Cellular Iron Transport. 2002;201-235 Marcel Dekker, New York.
24. Johansson H.E., Theil E.C. Templeton D.M. Molecular and Cellular Iron Transport. 2002;237-253 Marcel Dekker, New York.
25. Cairo G., Bardella L., Schiaffonati L., Arosio P., Levi S., Bernelli-Zazzera A. Multiple mechanisms of iron-induced ferritin synthesis in HeLa cells. Biochem. Biophys. Res. Commun. 133:1985;314-321.
26. Pietrangelo A., Rocchi E., Schiaffonati L., Ventura E., Cairo G. Liver gene expression during chronic dietary iron overload in rats. Hepatology. 11:1990;798-804.
27. Neupert B., Menotti E., Kühn L.C. A novel method to identify nucleic acid binding sites in proteins by scanning mutagenesis: application to iron regulatory protein. Nucleic Acids Res. 23:1995;2579-2583.
28. Henderson B.R., Menotti E., Kühn L.C. Iron regulatory proteins 1 and 2 bind distinct sets of RNA target sequences. J. Biol. Chem. 271:1996;4900-4908.
29. Menotti E., Henderson B.R., Kühn L.C. Translational regulation of mRNAs with distinct IRE sequences by iron regulatory proteins 1 and 2. J. Biol. Chem. 273:1998;1821-1824.
30. Klausner R.D., Rouault T.A., Harford J.B. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell. 72:1993;19-28.
31. Tchernitchko D., Bourgeois M., Martin M.E., Beaumont C. Expression of the two mRNA isoforms of the iron transporter Nrmap2/DMTI in mice and function of the iron responsive element. Biochem. J. 363:2002;449-455.
32. Hubert N., Hentze M.W. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc. Natl. Acad. Sci. U. S. A. 99:2002;12345-12350.
33. Lee P.L., Gelbart T., West C., Halloran C., Beutler E. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol. Diseases. 24:1998;199-215.
34. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 388:1997;482-488.
35. Wardrop S.L., Richardson D.R. The effect of intracellular iron concentration and nitrogen monoxide on Nramp2 expression and non-transferrin-bound iron uptake. Eur. J. Biochem. 263:1999;41-49.
36. Vidal S.M., Malo D., Vogan K., Skamene E., Gros P. Natural resistance to infections with intracellular parasites: isolation of a candidate for BCG. Cell. 73:1993;469-476.
37. Atkinson P.G.P., Barton C.H. Ectopic expression of Nramp1 in COS-1 cells modulates iron accumulation. FEBS Lett. 425:1998;239-242.
38. Hackam D.J., Rotstein O., Zhang D., Grunheid S., Gros P., Grinstein S. Host resistance to intracellular infection: mutation of natural resistance associated macrophage protein 1 impairs phagosomal acidification. J. Exp. Med. 188:1998;351-364.
39. Weiss G. Templeton D.M. Molecular and Cellular Iron Transport. 2002;467-486 Marcel Dekker, New York.
40. Beinert H., Kiley P. Redox control of gene expression involving iron-sulfur proteins. Change of oxidation-state or assembly disassembly of Fe-S clusters? FEBS Lett. 382:1996;218-219.
41. Beinert H., Holm R.H., Münck E. Iron-sulfur clusters: nature's modular, multipurpose structures. Science. 277:1997;653-659.
42. Brazzolotto X., Gaillard J., Pantopoulos R., Hentze M.W., Moulis J.M. Human cytoplasmic aconitase (iron regulatory protein 1) is converted into its [3Fe-4S] form by hydrogen peroxide in vitro but is not activated for iron-responsive element binding. J. Biol. Chem. 274:1999;21625-21630.
43. Gray N.K., Quick S., Goossen B., Constable A., Hirling H., Kühn L.C., Hentze M.W. Recombinant iron-regulatory factor functions as an iron-responsive-element-binding protein, a translational repressor and an aconitase - a functional assay for translational repression and direct demonstration of the iron switch. Eur. J. Biochem. 218:1993;657-667.
44. Iwai K., Klausner R.D., Rouault T.A. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J. 14:1995;5350-5357.
45. Guo B., Phillips J.D., Yu Y., Leibold E.A. Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome. J. Biol. Chem. 270:1995;21645-21651.
46. La Vaute T., Smith S., Cooperman S., Iwai K., Land W., Meyron-Holtz E., Drake S.K., Miller G., Abu-Asab M., Tsokos M., Switzer R.I.I., Grinberg A., Love P., Tresser N., Rouault T.A. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27:2001;209-214.
47. Beaumont C., Jones R., Seyhan A., Grandchamp B. A hemin-inducible enhancer lies 4.5 kb upstream of the mouse ferritin H subunit gene. Adv. Exp. Med. Biol. 356:1994;211-218.
48. Tsuji Y., Akebi N., Lam T.K., Nakabeppu Y., Torti S.V., Torti F.M. FER-1, an enhancer of the ferritin H gene and a target of E1A-mediated transcriptional repression. Mol. Cell. Biol. 15:1995;5152-5164.
49. Wasserman W.W., Fahl W.E. Functional antioxidant responsive elements. Proc. Natl. Acad. Sci. U. S. A. 94:1997;5361-5366.
50. White K., Munro H.N. Induction of ferritin subunit synthesis by iron is regulated at both the transcriptional and translational levels. J. Biol. Chem. 263:1988;8938-8942.
51. Kwak E.L., Larochelle D.A., Beaumont C., Torti S.V., Torti F.M. Role for NF-κB in the regulation of ferritin H by tumor necrosis factor-α J. Biol. Chem. 270:1995;15286-15293.
52. Li N.X., Karin M. Is NF-κB the sensor of oxidative stress? FASEB J. 13:1999;1137-1143.
53. Bonizzi G., Piette J., Merville M.-P., Bours V. Cell type-specific role for reactive oxygen species in nuclear factor-kappa B activation by interleukin-1. Biochem. Pharmacol. 59:2000;7-11.
54. Cairo G., Tacchini L., Pogliaghi G., Anzon E., Tomasi A., Bernelli-Zazzera A. Induction of ferritin synthesis by oxidative stress. Transcriptional and post-transcriptional regulation by expansion of the "free" iron pool. J. Biol. Chem. 270:1995;700-703.
55. Gaymard F., Boucherez J., Briat F. Characterization of ferritin mRNA from Arabidopsis thaliana accumulated in response to iron through an oxidative pathway independent of abscisic acid. Biochem. J. 318:1996;67-73.
56. Savino G., Briat J.F., Lobreaux S. Inhibition of the iron-induced ZmFer1 maize ferritin gene expression by antioxidants and serine/threonine phopshatase inhibitors. J. Biol. Chem. 272:1997;33319-33326.
57. Fan L.J., Iyer J., Zhu S.X., Frick K.K., Wada R.K., Eskenazi A.E., Berg P.E., Ikegaki N., Kennett R.H., Frantz C.N. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells. Cancer Res. 61:2001;1073-1079.
58. Wu K.J., Polack A., Dalla-Favera R. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science. 283:1999;676-679.
59. Bianchi L., Tacchini L., Cairo G. HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation. Nucleic Acids Res. 27:1999;4223-4227.
60. Louache F., Pelosi E., Titeux M., Peschle C., Testa U. Molecular mechanisms regulating the synthesis of transferrin receptors and ferritin in human erythroleukemic cell lines. FEBS Lett. 183:1985;223-227.
61. Rao K., Harford J.B., Rouault T., McClelland A., Ruddle F.H., Klausner R.D. Transcriptional regulation by iron of the gene for the transferrin receptor. Mol. Cell. Biol. 6:1986;236-240.
62. Casey J.L., Di Jeso B., Rao K., Klausner R.D., Harford J.B. Two genetic loci participate in the regulation by iron of the gene for the human transferrin receptor. Proc. Natl. Acad. Sci. U. S. A. 85:1988;1787-1791.
63. Wenger R.H., Gassmann M. Oxygen(es) and the hypoxia-inducible factor-1. Biol. Chem. 378:1997;609-616.
64. Semenza G.L. Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis. J. Lab. Clin. Med. 131:1998;207-214.
65. Lok C.N., Ponka P. Identification of a hypoxia response element in the transferrin receptor gene. J. Biol. Chem. 274:1999;24147-24152.
66. Tacchini L., Bianchi L., Bernelli-Zazzera A., Cairo G. Transferrin receptor induction by hypoxia: HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J. Biol. Chem. 274:1999;24142-24146.
67. Tong X.J., Kawabata H., Koeffler H.P. Iron deficiency can upregulate expression of transferrin receptor at both the mRNA and protein level. Br. J. Haematol. 116:2002;458-464.
68. Rolfs A., Kvietkova I., Gassmann M., Webger R.H. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J. Biol. Chem. 272:1997;20055-20062.
69. Lee P.J., Jiang B.-H., Chin B.Y., Iyer N.V., Alam J., Semenza G.L., Choi A.M.K. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase 1 gene in response to hypoxia. J. Biol. Chem. 272:1997;5375-5381.
70. Wang G.L., Semenza G.L. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity. Blood. 82:1993;3610-3615.
71. Ponka P. Templeton D.M. Molecular and Cellular Iron Transport. 2002;643-677 Marcel Dekker, New York.
72. Jiang B.-H., Zheng J.Z., Leung S.W., Roe R., Semenza G.L. Transactivation and inhibitory domains of hypoxia-inducible factor 1α: modulation and transcriptional activity by oxygen tension. J. Biol. Chem. 272:1997;19253-19260.
73. Gleadle J.M., Ebert B.L., Ratcliffe P.J. Diphenylene iodonium inhibits the induction of erythropoietin and other mammalian genes by hypoxia: implications for the mechanism of oxygen sensing. Eur. J. Biochem. 234:1995;92-99.
74. Ehleben W., Porwol T., Fandrey J., Kummer W., Acker H. Cobalt and desferrioxamine reveal crucial members of the oxygen sensing pathway in HepG2 cells. Kidney Int. 51:1997;483-491.
75. Maxwell P.H., Wiesener M.S., Chang G.-W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399:1999;271-275.
76. 2-regulated prolyl hydroxylation. Science. 292:2001;468-472.
77. Lando D., Peet D.J., Whelan D.A., Gorman J.J., Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science. 292:2002;858-861.
78. Alcantara O., Reddy S.V., Roodman G.D., Boldt D.H. Transcriptional regulation of the tartrate-resistant acid phosphatase (TRAP) gene by iron. Biochem. J. 298:1994;421-425.
79. Eisenstein R.S., Garcia-Mayol D., Pettingell W., Munro H.N. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc. Natl. Acad. Sci. U. S. A. 88:1991;688-692.
80. Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood. 89:1997;1-25.
81. Inamdar N.M., Ahn Y.I., Alam J. The heme-responsive element of the mouse heme oxygenase-1 gene is an extended AP-1 binding site that resembles the recognition sequences for MAF and NF-E2 transcription factors. Biochem. Biophys. Res. Commun. 221:1996;570-576.
82. Sassa S., Nagai T. The role of heme in gene expression. Int. J. Hematol. 63:1996;167-178.
83. Shan Y., Pepe J., Lambrecht R.W., Bonkovsky H.L. Mapping of the chick heme oxygenase-1 proximal promoter for responsiveness to metalloporphyrins. Arch. Biochem. Biophys. 399:2002;159-166.
84. Halliwell B. Oxidants and human disease: some new concepts. FASEB J. 1:1987;358-364.
85. Boldt D.H. New perspectives on iron: an introduction. Am. J. Med. Sci. 318:1999;207-212.
86. Biemond P., van Eijk H.G., Swaak A.J., Koster J.F. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases. J. Clin. Invest. 73:1984;1576-1579.
87. Michiels C., Raes M., Toussaint O., Remacle J. Importance of Se-Gltuathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic. Biol. Med. 17:1994;235-248.
88. Fuchs O. Effects of intracellular chelatable iron and oxidative stress on transcription of classical cellular glutathione peroxidase gene in murine erythroleukemia cells. Neoplasma. 44:1997;184-191.
89. Ye Z., Connor J.R. Screening of transcriptionally regulated genes following iron chelation in human astrocytoma cells. Biochem. Biophys. Res. Commun. 264:1999;709-713.
90. Alam J., Smith A. Receptor-mediated transport of heme by hemopexin regulates gene expression in mammalian cells. J. Biol. Chem. 264:1989;17637-17640.
91. Alam J., Smith A. Heme-hemopexin-mediated induction of metallothionein gene expression. J. Biol. Chem. 267:1992;16379-16384.
92. Ren Y., Smith A. Mechanism of metallothionein gene regulation by heme-hemopexin. J. Biol. Chem. 270:1995;23988-23998.
93. Brenneisen P., Wenk J., Klotz L.O., Wlaschek M., Briviba K., Krieg T., Sies H., Scharffetter-Kochanek K. Central role of ferrous/ferric iron in the ultraviolet B irradiation-mediated signaling pathway leading to increased interstitial collagenase (matrix-degrading metalloprotease (MMP)-1) and stromelysin-1 (MMP-3) mRNA levels in cultured human dermal fibroblasts. J. Biol. Chem. 273:1998;5279-5287.
94. waf1/cyp1, and erythropoietin. J. Neurosci. 19:1999;9821-9830.
95. Darnell G., Richardson D.R. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents: III. The effect of the ligands on molecular targets involved in proliferation. Blood. 94:1999;781-792.
96. Gao J., Richardson D.R. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents: IV. The mechanisms involved in inhibiting cell-cycle progression. Blood. 98:2001;842-850.
97. Asin J., Péres-Martos A., Fernández-Silva P., Montoya J., Andreu A.L. Iron(II) induces changes in the conformation of mammalian mitochondrial DNA resulting in a reduction of its transcriptional rate. FEBS Lett. 480:2000;161-164.
98. Parkes J.G., Liu Y., Sirna J.B., Templeton D.M. Changes in gene expression with iron loading and chelation in cardiac myocytes and non-myocytic fibroblasts. J. Mol. Cell. Cardiol. 32:2000;233-246.
99. Quail E.A., Yeoh G.C.T. The effect of iron status on glyceraldehyde 3-phosphate dehydrogenase expression in rat liver. FEBS Lett. 359:1995;126-128.
100. Ebert B.L., Firth J.D., Ratcliffe P.J. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences. J. Biol. Chem. 270:1995;29083-29089.
101. Houglum K., Bedossa P., Chojkier M. TGF-β and collagen-α1(I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload. Am. J. Physiol. 267:1994;G908-G913.
102. MacDonald G.A., Ward P.J., George D.K., Powell L.W. Iron and fibrosis in nonalcoholic fatty liver disease. Hepatology. 31:2000;549-550.
103. Short E.M., Winkle R.A., Billingham M.E. Myocardial involvement in idiopathic hemochromatosis. Morphologic and clinical improvement following venisection. Am. J. Med. 70:1981;1275-1279.
104. Lombardo T., Tamburino C., Bartoloni G., Morrone M.L., Frontini V., Italia F., Cordaro S., Privitera A., Calvi V. Cardiac iron overload in thalassemic patients: an endomyocardial biopsy study. Ann. Hematol. 71:1995;135-141.
105. Carthew P., Smith A.G., Hider R.C., Dorman B., Edwards R.B., Francis J.E. Potentiation of iron accumulation in cardiac myocytes during the treatment of iron overload in gerbils with the hydroxypyridinone iron chelator CP94. BioMetals. 7:1994;267-271.
106. Olivieri N.F., Brittenham G.M., McLaren C.E., Templeton D.M., Cameron R., McClelland R.A., Burt A., Fleming K. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N. Engl. J. Med. 339:1998;417-423.
107. Gualdi R., Casalgrandi G., Montosi G., Ventura E., Pietrangelo A. Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis. Gastroenterology. 107:1994;1118-1124.
108. Ikeda H., Wu G.Y., Wu C.H. Evidence that an iron chelator regulates collagen synthesis by decreasing the stability of procollagen mRNA. Hepatology. 15:1992;282-287.
109. Chojkier M., Houglum K., Soli-Herruzo J.A., Brenner D.A. Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts: a role for lipid peroxidation? J. Biol. Chem. 264:1989;16957-16962.
110. Ruiz I.G., De la Torre P., Diaz T., Esteban E., Morillas J.D., Muñoz-Yagüe T., Solís-Herruzo J.A. Sp family of transcription factors is involved in iron-induced collagen alpha1(I) gene expression. DNA Cell Biol. 19:2000;167-178.
111. Houglum K., Ramm G.A., Crawford D.H.G., Witztum J.L., Powell L.W., Chojkier M. Excess iron induces hepatic oxidative stress and transforming growth factor β1 in genetic hemochromatosis. Hepatology. 26:1997;605-610.
112. Border W.A., Noble N.A. Mechanisms of disease: transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 331:1994;1286-1292.
113. Haralson M.A. Transforming growth factor-β, other growth factors, and the extracellular matrix. J. Lab. Clin. Med. 130:1997;455-458.
114. Hildebrand A., Romarís M., Rasmussen L.M., Heinegård D., Twardzik D.R., Border W.A., Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor β Biochem. J. 302:1994;527-534.
115. Kim S.-J., Jeang K.-T., Glick A.B., Sporn M.B., Roberts A.B. Promoter sequences of the human transforming growth factor-β1 gene responsive to transforming growth factor-β1 autoinduction. J. Biol. Chem. 264:1989;7041-7045.
116. Kim S.J., Angel P., Lafyatis R., Hattori K., Kim K.Y., Sporn M.B., Karin M., Roberts A.B. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol. Cell. Biol. 10:1990;1492-1497.
117. Weber I.T., Harrison R.W., Iozzo R.V. Model structure of decorin and implications for collagen fibrillogenesis. J. Biol. Chem. 271:1996;31767-31770.
118. Danielson K.G., Baribault H., Holmes D.F., Graham H., Kadler K.E., Iozzo R.V. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol. 136:1997;729-743.
119. Pins G.D., Christiansen D.L., Patel R., Silver F.H. Self-assembly of collagen fibers. Influence of fibrillar alignment and decorin on mechanical properties. Biophys. J. 73:1997;2164-2172.
120. Gazitt Y., Reddy S.V., Alcantara O., Yang J., Boldt D.H. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells. Iron is required for transcription of p21(WAF1/CIPI) in cells induced by phorbol myristate acetate (PMA). J. Cell. Physiol. 187:2001;124-135.
121. Dlaska M., Weiss G. Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase espression. J. Immunol. 162:1999;6171-6177.
122. Tonetti D.A., Henning-Chubb C., Yamanishi D.T., Huberman E. Protein kinase C-beta is required for macrophage differentiation of human HL-60 leukemia cells. J. Biol. Chem. 269:1994;23230-23235.
123. Alcantara O., Obeid L., Hannun Y., Ponka P., Boldt D.H. Regulation of protein kinase C (PKC) expression by iron: effect of different iron compounds on PKC-β and PKC-α gene expression and role of the 5′-flanking region of the PKC-β gene in the response to ferric transferrin. Blood. 84:1994;3510-3517.
124. Lucas J.J., Szepesi A., Domenico J., Takase K., Tordai A., Terada N., Gelfand E.W. Effects of iron-depletion on cell cycle progression in normal human T lymphocytes: selective inhibition of the appearance of the cyclin A-associated component of the p33cdk2 kinase. Blood. 86:1995;2268-2280.
125. Kulp K.S., Green S.L., Vulliet P.R. Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells. Exp. Cell Res. 229:1996;60-68.
126. Terada N., Lucas J.J., Gelfand E.W. Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells. J. Immunol. 147:1991;698-704.
127. Furukawa T., Adachi Y., Fujisawa J., Kambe T., Yamaguchi-Iwai Y., Sasaki R., Kuwahara J., Ikehara S., Tokunaga R., Taketani S. Involvement of PLAGL2 in activation of iron deficient- and hypoxia-induced gene expression in mouse cell lines. Oncogene. 20:2001;4718-4727.
128. Tanji K., Imaizumi T., Matsumiya T., Itaya H., Fujimoto K., Cui X., Toki T., Ito E., Yosgida H., Wakabayashi K., Satoh K. Desferrioxamine, and iron chelator, upregulates cyclooxygenase-2 expression and prostaglandin production in a human macrophage cell line. Biochim. Biophys. Acta. 1530:2001;227-235.
129. Tsukamoto H. Iron regulation of hepatic macrophage TNF α expression. Free Radic. Biol. Med. 32:2002;309-313.
130. Lin M., Rippe R.A., Niemelä O., Brittenham G., Tsukamoto H. Role of iron in NF-κB activation and cytokine gene expression by rat hepatic macrophages. Am. J. Physiol. 272:1997;G1355-G1364.